SCHEMBL24865901

SCHEMBL24865901

CC(C)C1CCN(C(C)CCC(C)C2CCN(C(C)C)CC2(F)F)C(F)(F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24942057 0.88 — —
SCHEMBL24941857 0.88 — —
SCHEMBL25443994 0.84 — —
SCHEMBL25089971 0.82 — —
SCHEMBL24942060 0.78 — —
SCHEMBL25850549 0.74 — —
SCHEMBL24941849 0.72 OPRM1 (0.32) —
SCHEMBL24848325 0.71 — —
SCHEMBL22306681 0.71 — —
SCHEMBL26445266 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331722-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-10-19 — — US disclosed
WO-2023283263-A1 CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME FOGHORN THERAPEUTICS INC. (US) 2023-01-12 — — WO disclosed
Send feedback